Moreover, if only patients were taken into consideration who received surgery-mediated tumor removal plus accompanying radiotherapy, PON2 levels remained significantly elevated in the relapse-experiencing group, while it was lower in patients without relapse (Figure 7B). This evidence concerns the gene PON2 and neoplasm.